Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study. (Record no. 24421001)

MARC details
000 -LEADER
fixed length control field 02345 a2200625 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517004832.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201602s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1569-8041
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/annonc/mdu551
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bonnefoi, H
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160224
245 00 - TITLE STATEMENT
Title Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of oncology : official journal of the European Society for Medical Oncology
Date of publication, distribution, etc. Feb 2015
300 ## - PHYSICAL DESCRIPTION
Extent 325-32 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anthracyclines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemotherapy, Adjuvant
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Docetaxel
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epirubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorouracil
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lapatinib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoadjuvant Therapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinazolines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, ErbB-2
General subdivision biosynthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Taxoids
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Trastuzumab
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jacot, W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saghatchian, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Moldovan, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Venat-Bouvet, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zaman, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Matos, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Petit, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bodmer, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Quenel-Tueux, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chakiba, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vuylsteke, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jerusalem, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brain, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tredan, O
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Messina, C G M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Slaets, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cameron, D
773 0# - HOST ITEM ENTRY
Title Annals of oncology : official journal of the European Society for Medical Oncology
Related parts vol. 26
-- no. 2
-- p. 325-32
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/annonc/mdu551">https://doi.org/10.1093/annonc/mdu551</a>
Public note Available from publisher's website

No items available.